Stem cells in the treatment of patients with coronary heart disease. Part I

被引:1
|
作者
Zhukova, N. S.
Staroverov, I. I.
机构
[1] Russian Cardiology Scientific and Clinical Complex, Moscow
来源
CARDIOVASCULAR THERAPY AND PREVENTION | 2011年 / 10卷 / 02期
关键词
Myocardial infarction; ischemic cardiomyopathy; stem cells; ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; ACUTE MYOCARDIAL-INFARCTION; AUTOLOGOUS SKELETAL MYOBLASTS; ENHANCES COLLATERAL PERFUSION; CARDIAC STEM; REGENERATION ENHANCEMENT; ISCHEMIC MYOCARDIUM; REGIONAL FUNCTION; STATIN THERAPY;
D O I
10.15829/1728-8800-2011-2-122-128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) is one of the leading death causes in patients with myocardial infarction (MI). The modern methods of reperfusion MI therapy, such as thrombolysis, surgery and balloon revascularization, even when performed early, could fail to prevent the development of large myocardial damage zones, followed by HE Therefore, the researches have been searching for the methods which improve functional status of damaged myocardium. This review is focused on stem cell therapy, a method aimed at cardiac function restoration. The results of experimental and clinical studies on stem cell therapy in coronary heart disease are presented. Various types of stem cells, used for cellular cardiomyoplasty, are characterised. The methods of cell transplantation into myocardium and potential adverse effects of stem cell therapy are discussed.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 50 条
  • [41] MRI tracking stem cells transplantation for coronary heart disease
    Lu, Xi
    Xia, Rui
    Zhang, Bing
    Gao, Fabao
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2014, 30 (04) : 899 - 903
  • [42] Unsatisfactory blood pressure control in patients with established coronary heart disease. The Czech EUROASPIRE I - IV Surveys
    Bruthans, J.
    Cifkova, R.
    Galovcova, R.
    Belohoubek, J.
    Wohlfahrt, P.
    Kotseva, K.
    Wood, D.
    EUROPEAN HEART JOURNAL, 2014, 35 : 573 - 573
  • [43] Saving the heart: The battle to conquer coronary disease.
    Neville, T
    LIBRARY JOURNAL, 1999, 124 (20) : 172 - 172
  • [44] Neighborhood of residence and incidence of coronary heart disease.
    Roux, AVD
    Merkin, SS
    Arnett, D
    Chambless, L
    Massing, M
    Nieto, FJ
    Sorlie, P
    Szklo, M
    Tyroler, HA
    Watson, RL
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02): : 99 - 106
  • [45] Renal function in NIDDM with coronary heart disease.
    Courrèges, JP
    Pradier, P
    Bacha, J
    Aboud, E
    André, L
    Lamarca, R
    DIABETOLOGIA, 1999, 42 : A264 - A264
  • [46] Cardiac troponin I levels in pediatric patients with acquired heart disease.
    Williams, RV
    Olson, TM
    Young, PC
    Shaddy, RE
    PEDIATRICS, 1999, 104 (03) : 666 - 666
  • [47] Classification of ocular surface disease.: Part I
    Kruse, FE
    Cursiefen, C
    Seitz, B
    Völcker, HE
    Naumann, GOH
    Holbach, L
    OPHTHALMOLOGE, 2003, 100 (11): : 899 - +
  • [48] Neural stem cells for the treatment of the twitcher mouse model of Krabbe disease.
    Wenger, DA
    Snyder, EY
    Taylor, RM
    Vanier, MT
    Rafi, MA
    Luzi, P
    Datto, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A116 - A116
  • [49] Feasibility of percutaneous coronary intervention via a transulnar artery approach in patients with coronary heart disease.
    Sun, J
    Fu, X
    Liu, J
    Ma, N
    Wu, W
    Li, S
    Gi, X
    Miao, Q
    Jiang, Y
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 124E - 125E
  • [50] Detection of viability of dysfunctional myocardium in coronary heart disease. I. radionuclide imaging
    Manyari D.E.
    Humen D.P.
    Jugdutt B.I.
    Heart Failure Reviews, 1998, 2 (3) : 135 - 156